Back to search
Verified
Government
Health
Ryplle ID RYP-0302Last checked Oct 28, 2026

Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)

National Institutes of Health

Funding range
$0 – $10M
Application window
Opens: Not listed
Closes: November 10, 2026
Applications Status:Open
Location
National

Source & verification

Original funding source
www.grants.gov
Last checked
October 28, 2026
Last reviewed by Ryplle
Not yet recorded

Source checks may be automated. Review dates reflect a recorded staff review. Confirm current requirements with the funder.

Eligibility at a glance

Listed applicant types
Student, Business, Nonprofit
Geographic eligibility
National
Matching funds
Not specified — check with the funder
Major exclusions
Not specified — check with the funder

Listed types are not a determination of eligibility. The funder’s full requirements take precedence.

Full eligibility requirements

Eligible applicants: Public and State controlled institutions of higher education; City or township governments; For profit organizations other than small businesses; Private institutions of higher education; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; Special district governments; Independent school districts; Public housing authorities/Indian housing authorities; County governments; State governments; Native American tribal governments (Federally recognized); Small businesses; Native American tribal organizations (other than Federally recognized tribal governments); Others (see text field entitled "Additional Information on Eligibility" for clarification).

About this grant

The purpose of this notice of funding opportunity (NOFO) is to solicit applications for an Infectious Diseases Clinical Trials Network (IDCTN). The IDCTN, comprised of the Clinical Trial Evaluation Units (CTEUs) and a Network Coordination Center (NCC), supports the evaluation of interventions for emerging and chronic infections. The CTEUs design and implement clinical trials and studies, while the NCC provides the administrative and operational framework for a collaborative, integrated network and engages with experts in the field to solicit and generate clinical trial concepts. The NCC and CTEUs will collaboratively create opportunities to advance investigators early in their careers and those new to the field.

Contact information